Mathes Company, Inc. Organicell Regenerative Medicine, Inc. Transaction History

Mathes Company, Inc.

  • $283 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 18, 2022
BUY
$0.01 - $0.05 $300 - $1,500
30,000 New
30,000 $2,000

About Organicell Regenerative Medicine, Inc.

OCEL Quotes by TradingView
  • Ticker OCEL
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,476,130,048
  • Market Cap $1.7B
  • Description
  • Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs...
More about OCEL
Track This Portfolio

Track Mathes Company, Inc. Portfolio

Follow Mathes Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mathes Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mathes Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email